Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-23T18:41:35.743Z Has data issue: false hasContentIssue false
  • English
  • Français

Variability between nursing homes in prevalence of antipsychotic use in patients with dementia

Published online by Cambridge University Press:  20 November 2013

Bart C. Kleijer ,
Rob J. van Marum ,
Dinnus H. M. Frijters ,
Paul A. F. Jansen ,
Miel W. Ribbe ,
Antoine C. G. Egberts  and
Eibert R. Heerdink
Bart C. Kleijer
Affiliation:
Careyn Utrecht, Gerimedica, the Netherlands
Rob J. van Marum*
Affiliation:
Geriatric Department, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands
Dinnus H. M. Frijters
Affiliation:
Department of Nursing Home Medicine, VU University Medical Center, Amsterdam, the Netherlands EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
Paul A. F. Jansen
Affiliation:
Department of Geriatrics, University Medical Center Utrecht, Utrecht, the Netherlands
Miel W. Ribbe
Affiliation:
Department of Nursing Home Medicine, VU University Medical Center, Amsterdam, the Netherlands EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands
Antoine C. G. Egberts
Affiliation:
Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands
Eibert R. Heerdink
Affiliation:
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands
*
Correspondence should be addressed to: Rob van Marum, afdeling geriatrie, Jeroen Bosch Ziekenhuis, Postbus 90153, 5200 ME 's-Hertogenbosch, the Netherlands. Phone: +(31)73-553-8629; Fax: +(31)73-553-8555. Email: r.v.marum@jbz.nl.
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Antipsychotic drugs (APD) are widely prescribed for people with dementia residing in long term care facilities (LTCFs). Concern has been expressed that such prescribing is largely inappropriate. The objective of this study is to examine if differences in facility-level prevalence of APD use in a sample of LTCFs for patients with dementia can be explained by patient and facility-related characteristics.

Methods:

A point prevalence study was conducted using data from the VU University Resident Assessment Instrument (VURAI) database from nursing homes and residential care facilities in the Netherlands. Patients were selected who had a diagnosis of dementia. LTCF and patient characteristics were extracted from the VURAI; facility-level resident satisfaction surveys were provided by the National Institute for Public Health.

Results:

In total, 20 LTCFs providing care for 1,090 patients with dementia were investigated. Overall, 31% of patients used an APD. In facilities with a high prevalence of APD use behavioral symptoms were present in 62% of their patients. In facilities with medium APD use behavioral problems remained frequent (57%), and in facilities with low prevalence of APD use 54% of the patients had behavioral symptoms. Facilities with a high prevalence of APD use were often large, situated in urban communities, and scored below average on staffing, personal care, and recreational activities.

Conclusions:

There was considerable variation between the participating LTCFs in the prevalence of APD use. Variability was related to LTCF characteristics and patient satisfaction. This indicates potential inappropriate prescribing because of differences in institutional prescribing culture.

Keywords

dementialong-term careneuropsychiatric symptomsnursing homesantipsychotics
Type
Research Article
Information
International Psychogeriatrics , Volume 26 , Issue 3 , March 2014 , pp. 363 - 371
Copyright
Copyright © International Psychogeriatric Association 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Agency for Healthcare Research and Quality. (2003). Consumer Assessment of Healthcare Providers and Systems (CAHPS). Rockville, MD: Agency for Healthcare Research and Quality.Google Scholar
Azermai, M., Elseviers, M., Petrovic, M., van Bortel, L. and Stichele, R. V. (2011). Assessment of antipsychotic prescribing in Belgian nursing homes. International Psychogeriatrics, 23, 1240–1248. doi:S104161021100024X [pii]10.1017/S104161021100024XGoogle Scholar
Beer, C. et al. (2010). Factors associated with self and informant ratings of the quality of life of people with dementia living in care facilities: a cross sectional study. Public Library of Science One, 5, e15621. doi:10.1371/journal.pone.0015621 Google ScholarPubMed
Bronskill, S. E. et al. (2009). The relationship between variations in antipsychotic prescribing across nursing homes and short-term mortality: quality of care implications. Medical Care, 47, 1000–1008. doi:10.1097/MLR.0b013e3181a3943f Google Scholar
Chen, Y., Briesacher, B. A., Field, T. S., Tjia, J., Lau, D. T. and Gurwitz, J. H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170, 89–95. doi:170/1/89 [pii]10.1001/archinternmed.2009.469 Google Scholar
Cornege-Blokland, E., Kleijer, B. C., Hertogh, C. M. and van Marum, R. J. (2012). Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers. Journal of the American Medical Directors Association, 13, 80.e81–86. doi:S1525-8610(10)00365-8 [pii]10.1016/j.jamda.2010.10.004CrossRefGoogle ScholarPubMed
Devanand, D. P. et al. (2012). Relapse risk after discontinuation of risperidone in Alzheimer's disease. New England Journal of Medicine, 367, 1497–1507. doi:10.1056/NEJMoa1114058 Google Scholar
Finne-Soveri (2010). Measuring the quality of longterm institutional care in Finland. Eurohealth, 16, 8.Google Scholar
Fossey, J. et al. (2006). Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ, 332, 756–761. doi:bmj.38782.575868.7C [pii] 10.1136/bmj.38782.575868.7C CrossRefGoogle ScholarPubMed
Gerritsen, D., Ooms, M., Steverink, N., Frijters, D., Bezemer, D. and Ribbe, M. (2004). Three new observational scales for use in Dutch nursing homes: scales from the Resident Assessment Instrument for Activities of Daily Living, cognition and depression. Tijdschrift voor Gerontologie en Geriatrie, 35, 55–64.Google Scholar
Guthrie, B., Clark, S. A. and McCowan, C. (2010). The burden of psychotropic drug prescribing in people with dementia: a population database study. Age and Ageing, 39, 637–642. doi:afq090 [pii]10.1093/ageing/afq090 Google Scholar
Hartmaier, S. L., Sloane, P. D., Guess, H. A., Koch, G. G., Mitchell, C. M. and Phillips, C. D. (1995). Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 50, M128–133.Google Scholar
Huang, H. L., Chang, M. Y., Tang, J. S., Chiu, Y. C. and Weng, L. C. (2009). Determinants of the discrepancy in patient- and caregiver-rated quality of life for persons with dementia. Journal of Clinical Nursing, 18, 3107–3118. doi:JCN2537 [pii]10.1111/j.1365-2702.2008.02537.x Google Scholar
Hughes, C. M., Lapane, K., Watson, M. C. and Davies, H. T. (2007). Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs and Aging, 24, 81–93. doi:2421 [pii]Google Scholar
Huybrechts, K. F., Rothman, K. J., Silliman, R. A., Brookhart, M. A. and Schneeweiss, S. (2011). Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. Canadian Medical Association Journal, 183, E411–419. doi:cmaj.101406 [pii]10.1503/cmaj.101406 Google Scholar
Hyer, K., Thomas, K. S., Branch, L. G., Harman, J. S., Johnson, C. E. and Weech-Maldonado, R. (2011). The influence of nurse staffing levels on quality of care in nursing homes. Gerontologist, 51, 610–616. doi:gnr050 [pii]10.1093/geront/gnr050 Google Scholar
Kamble, P., Chen, H., Sherer, J. and Aparasu, R. R. (2008). Antipsychotic drug use among elderly nursing home residents in the United States. American Journal of Geriatric Pharmacotherapy, 6, 187.Google Scholar
Kleijer, B. C., et al. (2009). The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics. International Psychogeriatrics, 21, 931–940. doi:S1041610209990524 [pii]10.1017/S1041610209990524Google ScholarPubMed
Koehler, M. et al. (2005). Measuring depression in nursing home residents with the MDS and GDS: an observational psychometric study. Biomed Central Geriatrics, 5, 1. doi:1471-2318-5-1 [pii]10.1186/1471-2318-5-1 Google ScholarPubMed
Morris, J. N. et al. (1997). A commitment to change: revision of HCFA's RAI. Journal of the American Geriatrics Society, 45, 1011–1016.Google Scholar
Nijk, R. M., Zuidema, S. U. and Koopmans, R. T. (2009). Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. International Psychogeriatrics, 21, 485–493.Google Scholar
Ray, W. A., Federspiel, C. F. and Schaffner, W. (1980). A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. American Journal of Public Health, 70, 485–491.Google Scholar
Richter, T., Mann, E., Meyer, G., Haastert, B. and Kopke, S. (2012). Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. Journal of the American Medical Directors Association, 13, 187.e187–187.e113. doi:S1525-8610(11)00108-3 [pii]10.1016/j.jamda.2011.03.007 Google Scholar
Rochon, P. A. et al. (2007). Variation in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167, 676–683. doi:167/7/676 [pii]10.1001/archinte.167.7.676 Google Scholar
Ruths, S., Straand, J. and Nygaard, H. A. (2001). Psychotropic drug use in nursing homes–diagnostic indications and variations between institutions. European Journal of Clinical Pharmacology, 57, 523–528.Google Scholar
Schneider, L. S., Dagerman, K. and Insel, P. S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191.CrossRefGoogle ScholarPubMed
Shah, S. M., Carey, I. M., Harris, T., Dewilde, S. and Cook, D. G. (2011). Antipsychotic prescribing to older people living in care homes and the community in England and Wales. International Journal of Geriatric Psychiatry, 26, 423–434. doi:10.1002/gps.2557 Google Scholar
Snowden, M., Sato, K. and Roy-Byrne, P. (2003). Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature. Journal of the American Geriatrics Society, 51, 1305–1317. doi:51417 [pii]Google Scholar
Testad, I. et al. (2010). Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. International Journal of Geriatric Psychiatry, 25, 725–731. doi:10.1002/gps.2414 Google Scholar
Tornatore, J. B. and Grant, L. A. (2004). Family caregiver satisfaction with the nursing home after placement of a relative with dementia. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 59, S80–88.Google Scholar
Triemstra, M., Winters, S., Kool, R. B. and Wiegers, T. A. (2010). Measuring client experiences in long-term care in the Netherlands: a pilot study with the Consumer Quality Index Long-term Care. BioMed Central Health Services Research, 10, 95. doi:1472-6963-10-95 [pii]10.1186/1472-6963-10-95 CrossRefGoogle ScholarPubMed
Verbeek, H., van Rossum, E., Zwakhalen, S. M., Kempen, G. I. and Hamers, J. P. (2009). Small, homelike care environments for older people with dementia: a literature review. International Psychogeriatrics, 21, 252–264. doi:S104161020800820X [pii]10.1017/S104161020800820X Google Scholar
Verbeek, H., Zwakhalen, S. M., van Rossum, E., Ambergen, T., Kempen, G. I. and Hamers, J. P. (2010). Dementia care redesigned: effects of small-scale living facilities on residents, their family caregivers, and staff. Journal of the American Medical Directors Association, 11, 662–670. doi:S1525-8610(10)00250-1 [pii]10.1016/j.jamda.2010.08.001Google Scholar
Vernooij-Dassen, M., Vasse, E., Zuidema, S., Cohen-Mansfield, J. and Moyle, W. (2010). Psychosocial interventions for dementia patients in long-term care. International Psychogeriatrics, 22, 1121–1128. doi:S1041610210001365 [pii]10.1017/S1041610210001365Google Scholar
Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2011). Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians’ prescription behavior. International Psychogeriatrics, 23, 1632–1639. doi:S1041610211001438 [pii] 10.1017/S1041610211001438CrossRefGoogle ScholarPubMed